BVS
Income statement / Annual
Last year (2023), Bioventus Inc.'s total revenue was $512.35 M,
an increase of 0.04% from the previous year.
In 2023, Bioventus Inc.'s net income was -$156.23 M.
See Bioventus Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$512.35 M
|
$512.12 M
|
$430.90 M
|
$321.16 M
|
$340.14 M
|
$319.18 M
|
$292.06 M
|
$274.50 M
|
$253.65 M
|
$242.89 M
|
| Cost of Revenue |
$184.15 M |
$181.04 M |
$128.19 M |
$87.64 M |
$90.94 M |
$84.17 M |
$92.10 M |
$91.39 M |
$74.34 M |
$74.61 M |
| Gross Profit |
$328.19 M |
$331.08 M |
$302.71 M |
$233.52 M |
$249.21 M |
$235.01 M |
$199.96 M |
$183.11 M |
$179.31 M |
$168.28 M |
| Gross Profit Ratio |
0.64 |
0.65 |
0.7 |
0.73 |
0.73 |
0.74 |
0.68 |
0.67 |
0.71 |
0.69 |
| Research and Development
Expenses |
$13.45 M
|
$25.94 M
|
$19.04 M
|
$11.20 M
|
$11.06 M
|
$8.10 M
|
$8.10 M
|
$7.90 M
|
$14.75 M
|
$9.47 M
|
| General & Administrative
Expenses |
$300.03 M
|
$327.40 M
|
$250.38 M
|
$190.31 M
|
$196.12 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$3.85 M
|
$5.20 M
|
$3.87 M
|
$2.77 M
|
$2.35 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$303.88 M
|
$332.61 M
|
$254.25 M
|
$193.08 M
|
$198.48 M
|
$191.67 M
|
$164.84 M
|
$160.32 M
|
$148.44 M
|
$147.06 M
|
| Other Expenses |
$0.00 |
$21.15 M |
$8.36 M |
$7.44 M |
$7.91 M |
-$226,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$409.92 M |
$379.70 M |
$281.66 M |
$211.72 M |
$217.44 M |
$207.64 M |
$172.94 M |
$168.22 M |
$173.76 M |
$165.49 M |
| Cost And Expenses |
$594.07 M |
$560.74 M |
$409.85 M |
$299.36 M |
$308.37 M |
$291.81 M |
$265.04 M |
$259.61 M |
$248.10 M |
$240.10 M |
| Interest Income |
$0.00 |
$25.80 M |
$1.11 M |
$9.75 M |
$21.58 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$40.68 M |
$25.80 M |
$1.11 M |
$9.75 M |
$21.58 M |
$19.17 M |
$18.90 M |
$15.94 M |
$14.23 M |
$11.97 M |
| Depreciation &
Amortization |
$57.37 M
|
$61.40 M
|
$38.68 M
|
$28.64 M
|
$30.32 M
|
$29.24 M
|
$32.29 M
|
$33.76 M
|
$33.08 M
|
$28.82 M
|
| EBITDA |
-$23.07 M
|
-$109.21 M
|
$51.81 M
|
$50.44 M
|
$61.58 M
|
$54.52 M
|
$59.32 M
|
$48.65 M
|
$15.18 M
|
$34.42 M
|
| EBITDA Ratio |
-0.05 |
0.06 |
0.12 |
0.17 |
0.18 |
0.18 |
0.2 |
0.18 |
0.15 |
0.13 |
| Operating Income Ratio
|
-0.16
|
-0.07
|
0.04
|
0.07
|
0.09
|
0.08
|
0.09
|
0.05
|
-0.07
|
0
|
| Total Other
Income/Expenses Net |
-$39.39 M
|
-$21.79 M
|
-$2.57 M
|
-$5.32 M
|
-$21.50 M
|
-$19.40 M
|
-$18.37 M
|
-$20.54 M
|
-$15.38 M
|
-$11.37 M
|
| Income Before Tax |
-$121.11 M |
-$263.90 M |
$7.62 M |
$15.91 M |
$9.69 M |
$6.11 M |
$8.66 M |
-$5.65 M |
-$31.97 M |
-$11.35 M |
| Income Before Tax Ratio
|
-0.24
|
-0.52
|
0.02
|
0.05
|
0.03
|
0.02
|
0.03
|
-0.02
|
-0.13
|
-0.05
|
| Income Tax Expense |
$85,000.00 |
-$50.51 M |
-$1.97 M |
$1.19 M |
$1.58 M |
$1.66 M |
-$785,000.00 |
$1.09 M |
$2.14 M |
$1.55 M |
| Net Income |
-$156.23 M |
-$213.39 M |
$9.59 M |
$16.41 M |
$6.85 M |
-$12.21 M |
-$1.64 M |
-$17.95 M |
-$34.11 M |
-$12.90 M |
| Net Income Ratio |
-0.3 |
-0.42 |
0.02 |
0.05 |
0.02 |
-0.04 |
-0.01 |
-0.07 |
-0.13 |
-0.05 |
| EPS |
-2.49 |
-3.48 |
0.16 |
0.0771 |
-0.0116 |
-0.22 |
-0.0288 |
-0.32 |
-0.61 |
-0.23 |
| EPS Diluted |
-2.49 |
-3.48 |
0.16 |
0.0771 |
-0.0116 |
-0.22 |
-0.0288 |
-0.32 |
-0.61 |
-0.23 |
| Weighted Average Shares
Out |
$62.65 M
|
$61.39 M
|
$59.55 M
|
$56.83 M
|
$56.83 M
|
$55.63 M
|
$56.83 M
|
$56.83 M
|
$55.63 M
|
$55.63 M
|
| Weighted Average Shares
Out Diluted |
$62.65 M
|
$61.39 M
|
$59.55 M
|
$56.83 M
|
$56.83 M
|
$55.63 M
|
$56.83 M
|
$56.83 M
|
$55.63 M
|
$55.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
